This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of intravenous immunoglobulin (IVIG) for treatment of pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections (PANDAS).

If you have a Hayes login, click here to view the full report on the Knowledge Center.